The aims of this trial are to evaluate the efficacy and tolerability of pemetrexed in
patients with metastatic soft tissue sarcoma who have progressed after or during an
anthracycline-based chemotherapy and to assess the toxicity profile
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Tuebingen
Collaborators:
Arbeitsgemeinschaft fur Internistische Onkologie German Sarcoma Group